Abstract 419P
Background
Mammogram is a mandatory screening test for women from 40 years of age in the most parts of the world. While the structural screening for Coronary artery disease doesn’t exist but Women with breast cancer share common risk factors for coronary artery disease (CAD) as well. By using mammogram we can detect the potentially high risk patients, common for both the diseases and this is going to help in long way. Literature suggests that breast arterial classification exist in up to 8- 26% in women undergoing mammogram. In this study we have explored incidence of the total calcifications on mammogram and the percentage of people having Coronary artery diseases in a retrospective to manner.
Methods
It’s a retrospective observation of all mammograms done in past one year for routine screening from three institutes during the study period 2020-2021. Those with calcifications were interviewed and for the willing population we evaluated the coronary artery disease status clinically and radiologically. The mammogram calcifications were classified into mild, moderate, and severe as per the existing literature, so as the findings of the coronary angiogram. The incidence of the calcifications and the presence of CAD in the population were represented as percentages. Medcalc software version 10.1 was used for the analysis.
Results
There are 400 subjects whose complete case records besides the mammograms were available during the study period. Out of these patients 45 had some form of calcifications on mammograms with varying severity. Out of the 45 subjects 38 patients had coronary angiogram testing (either conventional or CT). We could observe 30 of them harboring moderate to severe atherosclerotic changes and varying degree of coronary artery stenosis.
Conclusions
Conclusion The results here hence strongly advocate the radiologists to report the same findings and should prompt the screening physician to encourage the patients for their cardiac risk assessment. In these multi-centre study patients with suspected coronary artery disease, our timely intervention changed the diagnosis and management of patients, who underwent mammogram for screening, but were unaware of the coronary disease, which led to improved outcomes on cardiac aspects.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
399P - Role of denosumab as targeted therapy in treatment of unresectable or recurrent cases of giant cell tumor of the bone
Presenter: Anchal Mishra
Session: Poster viewing 06
400P - Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel)
Presenter: Omid Hamid
Session: Poster viewing 06
401P - A phase Ib study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients (pts) with advanced solid tumors
Presenter: Shunsuke Kondo
Session: Poster viewing 06
402P - Phase I study of selumetinib in Chinese pediatric and adult patients (pts) with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN): Interim results
Presenter: Xiao-Jun Yuan
Session: Poster viewing 06
403P - Gender trend over time of principal investigators within large Australian cancer clinical trials groups
Presenter: Thi Thao Vi Luong
Session: Poster viewing 06
404P - Adolescent & young adult cancers (AYA): Experience from a large rural teaching hospital in South India
Presenter: Vishwapriya Godkhindi
Session: Poster viewing 06
405P - Evaluating medical oncology outcomes (EMOO) in Asia study: Diagnosis, staging, treatment patterns and outcome of patients with lung cancer registered 2017-2019
Presenter: Ross Soo
Session: Poster viewing 06
406P - Adrenal insufficiency induced by immune checkpoint inhibitors: Clinical characteristics of 145 cases
Presenter: kaoru koshiba
Session: Poster viewing 06
407P - A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
Presenter: Naoya Yamazaki
Session: Poster viewing 06
408P - Machine learning for glioblastoma screening from histopathology whole slide imaging
Presenter: Eva Yi Wah Cheung
Session: Poster viewing 06